|
1) O'Leary JG, Lepe R, Davis GL. Indications for liver transplantation. Gastroenterology. 2008; 134: 1764-76
|
|
|
|
2) 日本移植学会編集委員会, 編. 特集アジアの移植の現状. 移植. 2008; 43: 407-45
|
|
|
|
|
|
3) Adam R, Hoti E. Liver transplantation: the current situation. Semin Liver Dis. 2009; 29: 3-18
|
|
|
|
|
4) Freeman RB Jr, Steffick DE, Guidinger MK, at al. Liver and intestine transplantation in the United States, 1997-2006. Am J Transplant. 2008; 8: 958-76
|
|
|
|
|
|
5) Mukherjee S, Sorrell MF. Controversies in liver transplantation for hepatitis C. Gastroenterology. 2008; 134: 1777-88
|
|
|
|
|
|
6) Burra P. Hepatitis C. Semin Liver Dis. 2009; 29: 53-65
|
|
|
|
|
|
7) Forman LM, Lewis JD, Berlin JA, et al. The association between hepatitis C infection and survival after orthotopic liver transplantation. Gastroenterology. 2002; 122: 889-96
|
|
|
|
|
|
8) Thuluvath PJ, Krok KL, Segev DL, et al. Trends in post liver transplant survival in patients with hepatitis C between 1991 and 2001 in the United States. Liver Transpl. 2007; 13: 719-24
|
|
|
|
|
|
9) Berenguer M. Recurrent hepatitis C: worse outcomes established, interventions still inadequate. Liver Transpl. 2007; 13: 641-3
|
|
|
|
|
|
10) Wang CS, Ko HH, Yoshida EM, et al. Interferon-based combination anti-viral therapy for hepatitis C virus after liver transplantation: a review and quantitative analysis. Am J Transplant. 2006; 6: 1586-99
|
|
|
|
|
|
11) Tamura S, Sugawara Y. Treatment strategy for hepatitis C after liver transplantation. J Hepatobiliary Pancreat Surg. 2008; 15: 111-23
|
|
|
|
|
12) Mazzaferro V, Regalia E, Doci R, et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med. 1996; 334: 693-9
|
|
|
|
|
|
13) Neuberger J. Liver-cell cancer and transplantation. Lancet Oncol. 2009; 10: 5-7
|
|
|
|
|
|
14) Mazzaferro V, Chun YS, Poon RT, et al. Liver transplantation for hepatocellular carcinoma. Ann Surg Oncol. 2008; 15: 1001-7
|
|
|
|
|
|
15) Schwartz M, Roayaie S, Uva P. Treatment of HCC in patients awaiting liver transplantation. Am J Transplant. 2007; 7: 1875-81
|
|
|
|
|
|
16) Yao FY, Xiao L, Bass NM, et al. Liver transplantation for hepatocellular carcinoma: validation of the UCSF-expanded criteria based on preoperative imaging. Am J Transplant. 2007; 7: 2587-96
|
|
|
|
|
|
17) Yao FY, Kerlan RK Jr, Hirose R, et al. Excellent outcome following down-staging of hepatocellular carcinoma prior to liver transplantation: an intention-to-treat analysis. Hepatology. 2008; 48: 819-27
|
|
|
|
|
|
18) Mazzaferro V, Llovet JM, Miceli R, et al. Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis. Lancet Oncol. 2009; 10: 35-43
|
|
|
|
|
|
19) http://www.eltr.org/
|
|
|
|
|
|
20) http://www.eurotransplant.nl/files/annual_report/ar_2008.pdf
|
|
|
|
|
|
21) http://www.uktransplant.org.uk/ukt/
|
|
|
|
|
|
22) http://www.scandiatransplant.org/NLTR2008.pdf
|
|
|
|
|
|
23) http://www.agence-biomedecine.fr/
|
|
|
|
|
|
24) http://www.unos.org/data/about/viewDataReports.asp
|
|
|
|
|
|
25) http://www.ont.es/Home？id_nodo＝124
|
|
|
|
|
|
26) de Villa V, Lo CM. Liver transplantation for hepatocellular carcinoma in Asia. Oncologist. 2007; 12: 1321-31
|
|
|
|
|
|
27) Durand F, Renz JF, Alkofer B, et al. Report of the Paris consensus meeting on expanded criteria donors in liver transplantation. Liver Transpl. 2008; 14: 1694-707
|
|
|
|
|
|
28) Müllhaupt B, Dimitroulis D, Gerlach JT, et al. Hot topics in liver transplantation: organ allocation-extended criteria donor-living donor liver transplantation. J Hepatol. 2008; 48(Suppl 1): S58-67
|
|
|
|
|
|
29) Freeman RB, Cohen JT. Transplantation risks and the real world: what does ‘high risk' really mean？ Am J Transplant. 2009; 9: 23-30
|
|
|
|
|
|
30) Nery JR, Nery-Avila C, Reddy KR, et al. Use of liver grafts from donors positive for antihepatitis B-core antibody (anti-HBc) in the era of prophylaxis with hepatitis-B immunoglobulin and lamivudine. Transplantation. 2003; 75: 1179-86
|
|
|
|
|
|
31) Gane EJ, Angus PW, Strasser S, et al. Lamivudine plus low-dose hepatitis B immunoglobulin to prevent recurrent hepatitis B following liver transplantation. Gastroenterology. 2007; 132: 931-7
|
|
|
|
|
|
32) Velidedeoglu E, Desai NM, Campos L, et al. The outcome of liver grafts procured from hepatitis C donors. Transplantation. 2002; 73: 582-7
|
|
|
|
|
|
33) Marroquin CE, Marino G, Kuo PC, et al. Transplantation of hepatitis C-positive livers in hepatitis C-negative patients is equivalent to transplanting hepatitis C-negative livers. Liver Transpl. 2001; 7: 762-8
|
|
|
|
|
|
34) Khapra AP, Agarwal K, Fiel MI, et al. Impact of donor age on survival and fibrosis progression in patients with hepatitis C undergoing liver transplantation using HCV allografts. Liver Transpl. 2006; 12: 1496-503
|
|
|
|
|
|
35) Muiesan P, Girlanda R, Jassem W, et al. Single-center experience with liver transplantation from controlled non-heartbeating donors: a viable source of grafts. Ann Surg. 2005; 242: 732-8
|
|
|
|
|
|
36) Abt PL, Desai NM, Crawford MD, et al. Survival following liver transplantation from non-heart-beating donors. Ann Surg. 2004; 239: 87-92
|
|
|
|
|
|
37) http://www.konos.go.kr/
|
|
|
|
|
|
38) https://www.cltr.org/
|
|
|
|
|
|
39) Nivatvongs S, Dhitavat V, Jungsanasom A, et al. Recent organ transplant situation in Thailand. 移植. 2008; 43: 423-8
|
|
|
|
|
|
40) Nivatvongs S, Dhitavat V, Jungsangasom A, et al. Thirteen years of the Thai red cross organ donation centre. Transplant Proc. 2008; 40: 2091-4
|
|
|
|
|
|
41) Ghods AJ, Mahdavi M. Organ transplantation in Iran. Saudi J Kidney Dis Transpl. 2007; 18: 648-55
|
|
|
|
|
|
42) 日本肝移植研究会. 肝移植症例登録報告. 移植. 2008; 43: 458
|
|
|
|
|
|
43) http://www.jotnw.or.jp/index.html
|
|
|
|
|
|
44) http://www.jotnw.or.jp/datafile/newsletter/pdf/vol.12.pdf
|
|
|
|
|
|
45) Steering Committee of the Istanbul Summit. Organ trafficking and transplant tourism and commercialism: the Declaration of Istanbul. Lancet. 2008; 372: 5-6
|
|
|
|
|
|
46) http://www.prnewswire.com/mnr/transplantationsociety/33914/docs/33914-Declaration_of_Istanbul-Lancet.pdf
|
|
|
|
|
|
47) 国際移植学会(日本移植学会アドホック翻訳委員会). 臓器取引と移植ツーリズムに関するイスタンブール宣言. 移植. 2008; 43: 368-77
|
|
|
|
|
|
48) Akabayashi A. Japan's parliament passes brain-death law. Lancet. 1997; 349: 1895
|
|
|
|
|